Here's what most of our clients experience: you might feel more energetic within hours of your first treatment
In September 2025, the WHO added several GLP-1 drugs, including semaglutide and tirzepatide, to its Model List of Essential Medicines to improve global access to therapies used for diabetes and obesity-related conditions
NAD+ timeline: Most patients notice improved energy, reduced fatigue, and sharper mental clarity within two to four weeks of starting IV or injectable NAD+ therapy
Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG
ICH Harmonised Tripartite Guideline E6(R1): Guideline for Good Clinical Practice
mTOR: from growth signal integration to cancer, diabetes and ageing